2,955 Shares in Colgate-Palmolive (CL) Acquired by Bank of Stockton

Bank of Stockton purchased a new stake in shares of Colgate-Palmolive (NYSE:CL) during the 1st quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 2,955 shares of the company’s stock, valued at approximately $202,000.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Bank of New York Mellon Corp increased its stake in Colgate-Palmolive by 1.1% in the 3rd quarter. Bank of New York Mellon Corp now owns 20,359,199 shares of the company’s stock worth $1,363,050,000 after buying an additional 223,814 shares in the last quarter. Man Group plc grew its position in Colgate-Palmolive by 110.5% in the 3rd quarter. Man Group plc now owns 160,303 shares of the company’s stock valued at $10,732,000 after buying an additional 84,136 shares in the last quarter. Advisors Asset Management Inc. grew its position in Colgate-Palmolive by 5.1% in the 3rd quarter. Advisors Asset Management Inc. now owns 177,270 shares of the company’s stock valued at $11,868,000 after buying an additional 8,618 shares in the last quarter. Brown Brothers Harriman & Co. grew its position in Colgate-Palmolive by 2.0% in the 3rd quarter. Brown Brothers Harriman & Co. now owns 85,679 shares of the company’s stock valued at $5,736,000 after buying an additional 1,684 shares in the last quarter. Finally, AQR Capital Management LLC grew its position in Colgate-Palmolive by 47.8% in the 3rd quarter. AQR Capital Management LLC now owns 1,366,184 shares of the company’s stock valued at $91,466,000 after buying an additional 441,603 shares in the last quarter. 76.27% of the stock is currently owned by hedge funds and other institutional investors.

In other Colgate-Palmolive news, CEO Ian M. Cook sold 22,634 shares of Colgate-Palmolive stock in a transaction on Tuesday, February 19th. The stock was sold at an average price of $66.31, for a total transaction of $1,500,860.54. Following the completion of the transaction, the chief executive officer now directly owns 1,162,793 shares of the company’s stock, valued at $77,104,803.83. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CTO Patricia Verduin sold 2,218 shares of Colgate-Palmolive stock in a transaction on Tuesday, February 19th. The shares were sold at an average price of $66.38, for a total value of $147,230.84. Following the transaction, the chief technology officer now directly owns 48,671 shares of the company’s stock, valued at $3,230,780.98. The disclosure for this sale can be found here. Over the last three months, insiders have sold 85,450 shares of company stock valued at $5,682,621. Company insiders own 1.14% of the company’s stock.

CL has been the subject of a number of recent analyst reports. Goldman Sachs Group upgraded shares of Colgate-Palmolive from a “neutral” rating to a “buy” rating in a research report on Tuesday, January 8th. BNP Paribas upgraded Colgate-Palmolive from an “underperform” rating to a “neutral” rating and increased their price objective for the stock from $56.00 to $67.00 in a report on Monday, February 11th. Jefferies Financial Group restated a “hold” rating and issued a $61.00 price objective on shares of Colgate-Palmolive in a report on Friday, February 1st. Evercore ISI assumed coverage on Colgate-Palmolive in a report on Thursday, January 10th. They issued an “outperform” rating and a $70.00 price objective on the stock. Finally, Morgan Stanley set a $62.00 price objective on Colgate-Palmolive and gave the stock a “hold” rating in a report on Tuesday, January 29th. Three analysts have rated the stock with a sell rating, twelve have given a hold rating and four have assigned a buy rating to the company. Colgate-Palmolive presently has a consensus rating of “Hold” and a consensus target price of $65.73.

Shares of NYSE CL opened at $69.04 on Wednesday. The firm has a market cap of $59.08 billion, a price-to-earnings ratio of 23.25, a P/E/G ratio of 4.51 and a beta of 0.79. Colgate-Palmolive has a 52-week low of $57.41 and a 52-week high of $72.61. The company has a debt-to-equity ratio of 32.25, a current ratio of 1.14 and a quick ratio of 0.76.

Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings data on Friday, January 25th. The company reported $0.74 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $0.73 by $0.01. The company had revenue of $3.81 billion during the quarter, compared to analysts’ expectations of $3.78 billion. Colgate-Palmolive had a return on equity of 25,268.29% and a net margin of 15.44%. The business’s revenue was down 2.1% on a year-over-year basis. During the same period last year, the business earned $0.75 earnings per share. As a group, sell-side analysts predict that Colgate-Palmolive will post 2.83 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Shareholders of record on Friday, April 19th will be issued a dividend of $0.43 per share. The ex-dividend date is Wednesday, April 17th. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.42. This represents a $1.72 dividend on an annualized basis and a dividend yield of 2.49%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 56.57%.

ILLEGAL ACTIVITY NOTICE: “2,955 Shares in Colgate-Palmolive (CL) Acquired by Bank of Stockton” was originally reported by PressOracle and is the sole property of of PressOracle. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of U.S. & international copyright and trademark legislation. The original version of this piece can be read at https://pressoracle.com/news/2019/04/17/2955-shares-in-colgate-palmolive-cl-acquired-by-bank-of-stockton.html.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.

Featured Story: Trading Ex-Dividend Strategy

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.